TrialThe journal of prevention of Alzheimer's disease2022

Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults.

M H Silverman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.